Constellation Brands <STZ.N>: Barclays cuts target price to $132 from $139
STZ•Related News
Novo sues Lilly, claiming misleading ads in weight-loss drug battle
LLY•
Treasuries-yields rise as Iran conflict overshadows quiet data week
SPY•
U.S. Research Roundup-Colgate-Palmolive, IBM, UnitedHealth
UNH•
Brazil Potash Corp <GRO.A>: Canaccord Genuity initiates coverage with speculative buy rating; price target $5
GRO•
Another stab at green: Tech pushes US stock indexes higher
SPY•